Literature DB >> 26459892

Tigecycline Lock Therapy for Catheter-Related Bloodstream Infection Caused by KPC-Producing Klebsiella pneumoniae in Two Pediatric Hematological Patients.

Sergio Foresti1, Stefano Di Bella2, Attilio Rovelli3, Alessandra Sala3, Marta Verna3, Luca Bisi1, Carla Nisii4, Andrea Gori1.   

Abstract

Catheter-related bacteremias carry high mortality rates in hematological patients. When a multidrug-resistant microorganism is involved, the catheter should ideally be removed; however, this approach is not always possible. Tigecycline lock therapy was used in two pediatric oncohematological patients with intravascular catheter-related infection due to KPC-producing Klebsiella pneumoniae. The catheter was salvaged in both cases, and the patients were later discharged. Our experience suggests the usefulness of this approach in treating this type of infection.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26459892      PMCID: PMC4649240          DOI: 10.1128/AAC.01855-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement.

Authors:  Corrado Girmenia; Claudio Viscoli; Alfonso Piciocchi; Laura Cudillo; Stefano Botti; Antonio Errico; Loredana Sarmati; Fabio Ciceri; Franco Locatelli; Maddalena Giannella; Matteo Bassetti; Carlo Tascini; Letizia Lombardini; Ignazio Majolino; Claudio Farina; Francesco Luzzaro; Gian Maria Rossolini; Alessandro Rambaldi
Journal:  Haematologica       Date:  2015-04-10       Impact factor: 9.941

3.  Efficacy of tigecycline and vancomycin in experimental catheter-related Staphylococcus epidermidis infection: microbiological and electron microscopic analysis of biofilm.

Authors:  Yesim Aybar; Resat Ozaras; Kazim Besirli; Ersoy Engin; Ebru Karabulut; Tamer Salihoglu; Bilgul Mete; Fehmi Tabak; Ali Mert; Gulgun Tahan; M Halit Yilmaz; Recep Ozturk
Journal:  Int J Antimicrob Agents       Date:  2012-02-24       Impact factor: 5.283

Review 4.  Diagnosis and treatment of catheter-related infections in paediatric oncology: an update.

Authors:  A Simon; U Bode; K Beutel
Journal:  Clin Microbiol Infect       Date:  2006-07       Impact factor: 8.067

Review 5.  Antimicrobial lock therapy in central-line associated bloodstream infections: a systematic review.

Authors:  Matteo Vassallo; Brigitte Dunais; Pierre-Marie Roger
Journal:  Infection       Date:  2015-02-06       Impact factor: 3.553

6.  In vitro effectiveness of colistin, tigecycline and levofloxacin alone and combined with clarithromycin and/or heparin as lock solutions against embedded Acinetobacter baumannii strains.

Authors:  Berna Ozbek; Emel Mataraci
Journal:  J Antimicrob Chemother       Date:  2012-11-29       Impact factor: 5.790

Review 7.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003

  7 in total
  6 in total

1.  In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.

Authors:  Marta Rubia; Andrea Cordero; María Jesús Pérez-Granda; Emilia Cercenado; Cristina Pascual; Patricia Muñoz; María Guembe
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

2.  Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies.

Authors:  Shupeng Lin; Chenmei Zhang; Sheng Ye
Journal:  Int J Clin Pharm       Date:  2018-07-26

3.  Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.

Authors:  Maristela P Freire; Ligia C Pierrotti; Antonio E Zerati; Luciana Benites; Joaquim Mauricio da Motta-Leal Filho; Karim Y Ibrahim; Pedro H Araujo; Edson Abdala
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

4.  Preliminary experience with tigecycline treatment for severe infection in children.

Authors:  Sheng Ye; Chenmei Zhang; Shupeng Lin
Journal:  Eur J Pediatr       Date:  2018-07-14       Impact factor: 3.183

5.  Tigecycline treatment in a liver transplant infant with carbapenem-resistant Escherichia coli infection: Case report.

Authors:  Mei Yang; Hengmiao Gao; Xiaoling Wang; Suyun Qian
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

6.  A Dalbavancin Lock Solution Can Reduce Enterococcal Biofilms After Freezing.

Authors:  Marta Díaz-Navarro; Rama Hafian; Irene Manzano; María J Pérez-Granda; Emilia Cercenado; Cristina Pascual; Carmen Rodríguez; Patricia Muñoz; María Guembe
Journal:  Infect Dis Ther       Date:  2022-01-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.